Hagen Brett R

Chief Accounting Officer

1 company

Excellent

Trades Analyzed

12M Win Rate

97.7%

Avg 3M Return

+23.5%

Avg 12M Return

+61.4%

Hagen Brett R is a Chief Accounting Officer at Kalaris Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 14 sells.

Estimated insider holdings value: $9K based on current market prices.

Holdings by Company

KLRSMar 26, 2025

Current Shares1.9K

Value$9.1K

Net Activity-116,443

Bought: 0Sold: 116.4K

Showing 10 filings (page 3)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 4, 2024	KLRS Kalaris Therapeutics, Inc.	Chief Accounting Officer	Sell	310	$0.64	$198.09	-0.3%	+14.3%	-32.4%
Dec 27, 2023	KLRS Kalaris Therapeutics, Inc.	Chief Accounting Officer	Sell	28,335	$0.74	$20,837.56	-22.5%	+7.3%	-32.3%
Nov 17, 2023	KLRS Kalaris Therapeutics, Inc.	Chief Accounting Officer	Sell	403	$1.63	$657.33	-0.3%	-57.7%	-65.1%
Oct 20, 2023	KLRS Kalaris Therapeutics, Inc.	Chief Accounting Officer	Sell	715	$1.56	$1,115.78	-0.3%	-54.3%	-48.8%
Oct 3, 2023	KLRS Kalaris Therapeutics, Inc.	Chief Accounting Officer	Sell	222	$1.98	$438.74	-0.2%	-66.4%	-59.8%
Aug 17, 2023	KLRS Kalaris Therapeutics, Inc.	Chief Accounting Officer	Sell	1,653	$2.50	$4,125.06	-1.3%	-32.0%	-69.9%
Jul 20, 2023	KLRS Kalaris Therapeutics, Inc.	Chief Accounting Officer	Sell	684	$3.45	$2,362.84	-0.3%	-51.4%	-77.5%
Jun 9, 2023	KLRS Kalaris Therapeutics, Inc.	Chief Accounting Officer	Sell	5,045	$5.64	$28,452.79	-3.7%	-46.0%	-85.8%
Apr 20, 2023	KLRS Kalaris Therapeutics, Inc.	Chief Accounting Officer	Sell	697	$3.67	$2,555.93	-0.3%	-10.1%	-80.2%
Jan 20, 2023	KLRS Kalaris Therapeutics, Inc.	Chief Accounting Officer	Sell	1,895	$5.09	$9,644.58	-1.3%	-28.0%	-87.0%